Dr. Sagger Hameed Mawri, MD

Dr. Mawri practices at Miami Valley Hospital in Dayton, Ohio, part of Premier Health.

Dr. Mawri's NPI, 1750725487, was assigned on April 24, 2013. Dr. Mawri holds Louisiana license 322142.

Dr. Mawri's primary practice is Miami Valley Hospital, at One Wyoming Street, Dayton, OH 45409 in Montgomery County. The practice phone is (937) 208-3023. Dr. Mawri also practices at Miami Valley Hospital, 1 Wyoming St, Dayton, OH 45409.

Dr. Mawri's primary practice is Miami Valley Hospital in Dayton, Ohio, part of Premier Health. Dr. Mawri is also affiliated with Kettering Health Dayton. The medical group on file is Premier Health Specialists. Dmand AI also links Dr. Mawri to 3 more hospitals, 5 medical groups, 2 group practices and clinics and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mawri practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Mawri's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Mawri is licensed in Louisiana.

CMS data shows 2,211 Medicare services from Dr. Mawri across 22 procedure codes in 2024, for 1,420 Medicare patients. Medicare paid $105,775 for them.

CMS counts 1,420 Medicare patients who saw Dr. Mawri in 2024. The largest group is 75 to 84, with 566 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mawri's median patient age at 71, with 47% women.

In 2024, Dr. Mawri wrote 1,889 Medicare Part D claims for 497 patients. 94% of them were for generic drugs. CMS names the drug for 1,720 of them, across 28 drugs with 11 or more claims each, at $108,683 in total drug cost. In 2023, CMS named 1,910 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Mawri for performance year 2024, reported as part of a group. Dr. Mawri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of leg revascularization (restoring blood flow) by Dr. Mawri, more than 70% of the clinicians it reports for that procedure.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Mawri, published from 2015 to 2021. 2015 was the busiest year, with 3. The most frequent topics are COVID-19, Electrocardiography and Myocardial Infarction. Dr. Mawri has published most often in Crit Pathw Cardiol. Dr. Mawri's most frequent co-authors are Khaldoon Alaswad, MD, Said Ashraf, MD and Marie Hersey Bernardo, MD.

Dmand AI links Dr. Mawri to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 65 general payments to Dr. Mawri from 20 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 60% of the total. Boston Scientific Corporation paid the most, $2,353.